Morgan Stanley’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.2M Buy
989,589
+231,808
+31% +$9.63M ﹤0.01% 2370
2025
Q4
$35.2M Buy
757,781
+553,412
+271% +$26.7M ﹤0.01% 2419
2025
Q3
$10M Buy
204,369
+101,592
+99% +$5.31M ﹤0.01% 3549
2025
Q2
$5.32M Buy
+102,777
New +$4.15M ﹤0.01% 4016

Other funds holding HNGE

Morgan Stanley's HNGE Position: Q1 2026 in Review

Morgan Stanley increased its Hinge Health (HNGE) stake by 31% in Q1 2026, buying an estimated $9.63M and bringing the position to 989,589 shares worth $38.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Morgan Stanley first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Morgan Stanley held 989,589 shares of Hinge Health worth $38.2M as of Q1 2026.
  • Morgan Stanley bought 231,808 Hinge Health shares in Q1 2026, an estimated $9.63M.
  • Hinge Health made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2370 holding.
  • Morgan Stanley first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.